Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS

Publication

Journal of neuro-oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1185964

Publication Year

2014

PubMed ID

25411098

Publication Title

Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. J Neurooncol. 2015 Feb; 121(3):557-63.